Skip to main content
AXGN
NASDAQ Industrial Applications And Services

Axogen Finalizes $124M Common Stock Offering at Discount, Repays Credit Facility

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$32
Mkt Cap
$1.476B
52W Low
$9.215
52W High
$34.705
52W Position info
247% above low
Off High info
7.8% below high
Rel. Volume info
3.5× avg
Market data snapshot near publication time

AXGN has more than doubled off its 52-week low of $9.215 on elevated volume (3.5× avg).

Summary

Axogen, Inc. finalized an underwritten public offering of 4 million shares of common stock at $31.00 per share, raising $124 million, with an option for an additional $18.6 million, primarily to repay its credit facility.


Key Events · Financing and Capital Events · AXGN

  • Finalizes Common Stock Offering

    Axogen finalized an underwritten public offering of 4,000,000 shares of common stock at $31.00 per share, raising $124 million.

  • Underwriters' Over-Allotment Option

    Underwriters have a 30-day option to purchase an additional 600,000 shares, potentially increasing total proceeds by $18.6 million.

  • Strategic Debt Repayment

    Approximately $69.7 million of the net proceeds will be used for the early payoff and termination of the company's credit facility.

  • Share Dilution

    The offering, priced at a discount to recent market prices, will result in immediate and substantial dilution for existing shareholders.


Analysis · AXGN · Industrial Applications And Services

This 424B5 filing finalizes the terms and pricing of a significant common stock offering, which was initiated on January 21, 2026. The offering of 4 million shares at $31.00 per share, with an additional 600,000 shares option, could raise up to $142.6 million. This represents a substantial capital raise, leading to nearly 10% dilution for existing shareholders. A significant portion of the net proceeds, approximately $69.7 million, is allocated for the early payoff and termination of the company's credit facility, which is a positive step for balance sheet health and reducing financial risk. The offering price of $31.00 per share is at a discount to the last reported sale price of $33.01 on January 21, 2026, and today's price of $32.00.

At the time of this filing, AXGN was trading at $32.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $9.22 to $34.71. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AXGN - Latest Insights

AXGN
Apr 29, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $41.81
Real-time Price: $40.54 info
Change: -$1.28 (-3%) info
Market Cap: $2.156B info
AXGN
Apr 28, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $42.43
Real-time Price: $40.54 info
Change: -$1.89 (-4%) info
Market Cap: $2.156B info
AXGN
Apr 28, 2026, 7:13 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $47.89
Real-time Price: $40.54 info
Change: -$7.36 (-15%) info
Market Cap: $2.156B info
AXGN
Apr 28, 2026, 7:02 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $49.30
Real-time Price: $40.54 info
Change: -$8.77 (-18%) info
Market Cap: $2.156B info
AXGN
Feb 24, 2026, 4:24 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $32.44
Real-time Price: $40.54 info
Change: +$8.09 (+25%) info
Market Cap: $2.156B info